ResMed Statistics
Total Valuation
ResMed has a market cap or net worth of AUD 54.63 billion. The enterprise value is 55.26 billion.
Market Cap | 54.63B |
Enterprise Value | 55.26B |
Important Dates
The last earnings date was Friday, October 25, 2024.
Earnings Date | Oct 25, 2024 |
Ex-Dividend Date | Nov 6, 2024 |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | +0.02% |
Shares Change (QoQ) | +0.04% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 145.81M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 21.37, with an EV/FCF ratio of 28.31.
EV / Earnings | 34.43 |
EV / Sales | 7.46 |
EV / EBITDA | 21.37 |
EV / EBIT | 24.14 |
EV / FCF | 28.31 |
Financial Position
The company has a current ratio of 2.92, with a Debt / Equity ratio of 0.16.
Current Ratio | 2.92 |
Quick Ratio | 1.44 |
Debt / Equity | 0.16 |
Debt / EBITDA | 0.51 |
Debt / FCF | 0.63 |
Interest Coverage | 40.98 |
Financial Efficiency
Return on equity (ROE) is 23.56% and return on invested capital (ROIC) is 15.72%.
Return on Equity (ROE) | 23.56% |
Return on Assets (ROA) | 13.27% |
Return on Capital (ROIC) | 15.72% |
Revenue Per Employee | 694,773 |
Profits Per Employee | 160,833 |
Employee Count | 9,980 |
Asset Turnover | 0.69 |
Inventory Turnover | 1.82 |
Taxes
In the past 12 months, ResMed has paid 335.18 million in taxes.
Income Tax | 335.18M |
Effective Tax Rate | 18.95% |
Stock Price Statistics
The stock price has increased by +62.42% in the last 52 weeks. The beta is 0.69, so ResMed's price volatility has been lower than the market average.
Beta (5Y) | 0.69 |
52-Week Price Change | +62.42% |
50-Day Moving Average | 36.31 |
200-Day Moving Average | 32.62 |
Relative Strength Index (RSI) | 51.91 |
Average Volume (20 Days) | 1,074,159 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 7.76 |
Income Statement
In the last 12 months, ResMed had revenue of AUD 6.93 billion and earned 1.61 billion in profits. Earnings per share was 10.87.
Revenue | 6.93B |
Gross Profit | 4.04B |
Operating Income | 2.14B |
Pretax Income | 1.98B |
Net Income | 1.61B |
EBITDA | 2.35B |
EBIT | 2.14B |
Earnings Per Share (EPS) | 10.87 |
Balance Sheet
The company has 638.33 million in cash and 1.23 billion in debt, giving a net cash position of -587.98 million.
Cash & Cash Equivalents | 638.33M |
Total Debt | 1.23B |
Net Cash | -587.98M |
Net Cash Per Share | n/a |
Equity (Book Value) | 7.49B |
Book Value Per Share | 51.05 |
Working Capital | 2.51B |
Cash Flow
In the last 12 months, operating cash flow was 2.08 billion and capital expenditures -125.86 million, giving a free cash flow of 1.95 billion.
Operating Cash Flow | 2.08B |
Capital Expenditures | -125.86M |
Free Cash Flow | 1.95B |
FCF Per Share | n/a |
Margins
Gross margin is 58.33%, with operating and profit margins of 30.84% and 23.15%.
Gross Margin | 58.33% |
Operating Margin | 30.84% |
Pretax Margin | 28.62% |
Profit Margin | 23.15% |
EBITDA Margin | 33.95% |
EBIT Margin | 30.84% |
FCF Margin | 28.15% |
Dividends & Yields
This stock pays an annual dividend of 0.46, which amounts to a dividend yield of 1.23%.
Dividend Per Share | 0.46 |
Dividend Yield | 1.23% |
Dividend Growth (YoY) | -65.43% |
Years of Dividend Growth | 2 |
Payout Ratio | 26.02% |
Buyback Yield | -0.02% |
Shareholder Yield | -0.02% |
Earnings Yield | n/a |
FCF Yield | n/a |
Stock Splits
The last stock split was on August 12, 2010. It was a forward split with a ratio of 2.
Last Split Date | Aug 12, 2010 |
Split Type | Forward |
Split Ratio | 2 |
Scores
ResMed has an Altman Z-Score of 10.95 and a Piotroski F-Score of 5.
Altman Z-Score | 10.95 |
Piotroski F-Score | 5 |